Related Experiment Video
Updated: May 13, 2025
05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
5.1K
Spatial Metabolomics and Lipidomics in Kidney Disease
Brittney L Gorman1, Jessica K Lukowski2
1Pacific Northwest National Lab, Richland WA.
Seminars in Nephrology
|April 15, 2025
Summary
Spatial metabolomics using mass spectrometry imaging (MSI) maps lipids in kidney tissue. This approach aids early detection of kidney disease by revealing lipid changes in specific kidney structures, offering new clinical insights.
Area of Science:
- Nephrology
- Metabolomics
- Biochemistry
Background:
- Kidney disease affects over 850 million people globally.
- Dysregulation of lipid metabolism is linked to kidney diseases.
- Early detection is crucial for preventing severe kidney disease and complications.
Purpose of the Study:
- To review the application of spatial metabolomics via mass spectrometry imaging (MSI) in kidney disease research.
- To highlight how MSI provides spatial mapping of lipids within kidney tissue.
- To demonstrate the utility of MSI in understanding kidney disease mechanisms.
Main Methods:
- Utilizing various mass spectrometry imaging (MSI) techniques, including MALDI and DESI.
- Analyzing spatial distribution of lipids and small molecules in kidney tissue.
- Integrating spatial metabolomics data with pathology, transcriptomics, or proteomics.
Main Results:
- MSI enables detailed spatial mapping of lipids within kidney functional units (e.g., glomeruli, tubules).
- Characterization of lipid changes in various kidney conditions like chronic kidney disease, acute kidney injury, genetic kidney disease, and cancer.
- Demonstration of how spatial metabolomics data pinpoints the localization of molecular alterations in disease states.
Conclusions:
- Spatial metabolomics is a powerful tool for understanding kidney disease.
- MSI provides critical information on lipid localization and changes in kidney pathologies.
- Integration with other 'omics' approaches offers deeper insights into disease mechanisms and potential clinical applications.
